In Western blot analysis of markers associated with tumor growth and proliferation, treatment with STA-8666 compound caused a greater inhibition of ERK1/2 activity than irinotecan in both cell lines, and a greater inhibition of AKT in A549 cells (Fig 5B and 5C). Here, MAPK3 is linked to neoplasm.